NL8420264A - Werkwijze voor het bereiden van medicinale cosmetische preparaten. - Google Patents
Werkwijze voor het bereiden van medicinale cosmetische preparaten. Download PDFInfo
- Publication number
- NL8420264A NL8420264A NL8420264A NL8420264A NL8420264A NL 8420264 A NL8420264 A NL 8420264A NL 8420264 A NL8420264 A NL 8420264A NL 8420264 A NL8420264 A NL 8420264A NL 8420264 A NL8420264 A NL 8420264A
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- protein
- blood
- trace elements
- plasma
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 21
- 238000000034 method Methods 0.000 title claims description 17
- 239000002537 cosmetic Substances 0.000 title claims description 5
- 239000011573 trace mineral Substances 0.000 claims description 20
- 235000013619 trace mineral Nutrition 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 210000004369 blood Anatomy 0.000 claims description 14
- 239000008280 blood Substances 0.000 claims description 14
- 210000002381 plasma Anatomy 0.000 claims description 10
- 241000894007 species Species 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 6
- 229910010272 inorganic material Inorganic materials 0.000 claims description 4
- 239000011147 inorganic material Substances 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000011261 inert gas Substances 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 239000008239 natural water Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000006071 cream Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001172 regenerating effect Effects 0.000 description 5
- 102000004506 Blood Proteins Human genes 0.000 description 4
- 108010017384 Blood Proteins Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- -1 gold (III) ions Chemical class 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010010957 Copper deficiency Diseases 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010013883 Dwarfism Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229910003803 Gold(III) chloride Inorganic materials 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical compound [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical compound Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU358283 | 1983-10-17 | ||
| HU833582A HUT37342A (en) | 1983-10-17 | 1983-10-17 | Process for production of preparatives for medical cosmetics |
| PCT/HU1984/000050 WO1985001653A1 (en) | 1983-10-17 | 1984-10-17 | Process for the preparation of medicinal cosmetic compositions |
| HU8400050 | 1984-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8420264A true NL8420264A (nl) | 1985-09-02 |
Family
ID=10964641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8420264A NL8420264A (nl) | 1983-10-17 | 1984-10-17 | Werkwijze voor het bereiden van medicinale cosmetische preparaten. |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS61500358A (xx) |
| KR (1) | KR850700008A (xx) |
| AU (1) | AU3551084A (xx) |
| DE (1) | DE3490488T1 (xx) |
| DK (1) | DK273585A (xx) |
| FI (1) | FI852341A0 (xx) |
| GB (1) | GB2164848A (xx) |
| HU (1) | HUT37342A (xx) |
| NL (1) | NL8420264A (xx) |
| NO (1) | NO852427L (xx) |
| SE (1) | SE8502997D0 (xx) |
| WO (1) | WO1985001653A1 (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1243957A (en) * | 1983-06-03 | 1988-11-01 | Laszlo Bogdany | Compositions for cosmetic, health- and body- preserving use |
| FR2572287A1 (fr) * | 1984-10-26 | 1986-05-02 | Caola Kozmetikai | Procede de preparation de compositions cosmetiques medicinales |
| AU617661B2 (en) * | 1987-02-24 | 1991-12-05 | Thermalife International Pharmaceuticals Limited | A method for manufacturing cosmetical, health and body care products |
| US5527779A (en) * | 1988-03-23 | 1996-06-18 | Top Gold Pty Limited | Topically applied gold organic complex |
| NZ228367A (en) * | 1988-03-23 | 1992-02-25 | Smithkline Beecham Corp | Topical composition containing a gold compound for treating inflammatory conditions |
| US5013726A (en) * | 1989-09-12 | 1991-05-07 | Ivy Jeffery W | External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion |
| US5124320A (en) * | 1989-09-12 | 1992-06-23 | Ivy Jeffery W | An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion |
| US20070048387A1 (en) * | 2005-09-01 | 2007-03-01 | Edwards Jeffrey D | Tissue disruption treatment and composition for use thereof |
| CN103033632B (zh) * | 2012-12-12 | 2014-10-22 | 英科新创(厦门)科技有限公司 | Abo血型反定型胶体金试剂盒及制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU101771A1 (ru) * | 1954-05-04 | 1900-01-01 | А.А. Дыскин | Способ насыщени углекислым газом цитратной донорской крови и устройство дл осуществлени способа |
| SU523695A1 (ru) * | 1973-12-14 | 1976-08-05 | Курганский Научно-Исследовательский Институт Экспериментальной И Клинической Ортопедии И Травматологии | Способ остановки кровотечени |
| SU777903A1 (ru) * | 1978-12-26 | 1981-12-15 | Ленинградский Ордена Трудового Красного Знамени Научно-Исследовательский Институт Гематологии И Переливания Крови | Способ получени аминокислотного препарата дл парентерального питани |
| SU741877A1 (ru) * | 1979-06-06 | 1980-06-25 | За витель Р. Н. Ходанова | Способ лечени аллергических заболеваний |
-
1983
- 1983-10-17 HU HU833582A patent/HUT37342A/hu unknown
-
1984
- 1984-10-17 AU AU35510/84A patent/AU3551084A/en not_active Abandoned
- 1984-10-17 DE DE19843490488 patent/DE3490488T1/de not_active Withdrawn
- 1984-10-17 WO PCT/HU1984/000050 patent/WO1985001653A1/en active Application Filing
- 1984-10-17 JP JP59504031A patent/JPS61500358A/ja active Pending
- 1984-10-17 GB GB08514467A patent/GB2164848A/en not_active Withdrawn
- 1984-10-17 KR KR1019850700088A patent/KR850700008A/ko not_active Application Discontinuation
- 1984-10-17 NL NL8420264A patent/NL8420264A/nl unknown
-
1985
- 1985-06-12 FI FI852341A patent/FI852341A0/fi not_active Application Discontinuation
- 1985-06-14 NO NO852427A patent/NO852427L/no unknown
- 1985-06-17 SE SE8502997A patent/SE8502997D0/xx not_active Application Discontinuation
- 1985-06-17 DK DK273585A patent/DK273585A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK273585D0 (da) | 1985-06-17 |
| SE8502997L (sv) | 1985-06-17 |
| GB8514467D0 (en) | 1985-07-10 |
| DE3490488T1 (de) | 1985-10-17 |
| WO1985001653A1 (en) | 1985-04-25 |
| JPS61500358A (ja) | 1986-03-06 |
| FI852341L (fi) | 1985-06-12 |
| GB2164848A (en) | 1986-04-03 |
| KR850700008A (ko) | 1985-10-21 |
| NO852427L (no) | 1985-06-14 |
| FI852341A0 (fi) | 1985-06-12 |
| DK273585A (da) | 1985-06-17 |
| AU3551084A (en) | 1985-05-07 |
| HUT37342A (en) | 1985-12-28 |
| SE8502997D0 (sv) | 1985-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1293444C (en) | Amino acid chelated compositions for delivery to specific biologicaltissue sites | |
| DE69533593D1 (de) | Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten. | |
| US3856805A (en) | Silver zinc allantoin complex | |
| CN105107007B (zh) | 一种阳离子医用护创敷料及其制备方法 | |
| NO169291C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt | |
| US6579540B1 (en) | Use of physiologically acceptable vanadium compounds, salts and complexes | |
| NL8420264A (nl) | Werkwijze voor het bereiden van medicinale cosmetische preparaten. | |
| CN1145031A (zh) | 用于皮肤和毛发的淀粉-金属配合物 | |
| US4863897A (en) | Protein and mineral water-containing cosmetic compositions | |
| FI82598B (fi) | Kosmetiska kompositioner avsedda foer utvaertesbruk. | |
| JPH06312922A (ja) | 美白剤 | |
| CA1277271C (en) | Process for cultivating procaryotes and eucaryotes and use of the thus-prepared cells in cosmetical, food industry and fodder supplementing compositions | |
| US20020006892A1 (en) | Serum albumin compositions for use in cleansing or dermatological products for skin or hair | |
| KR860002196B1 (ko) | 미용과 건강 및 신체보호를 위한 조성물의 제조방법 | |
| JP2003040783A (ja) | 医薬品や健康食品としてのタングステン酸塩やモリブデン酸塩と霊芝胞子添加物 | |
| RU2007181C1 (ru) | Способ получения биологического материала для основы мягких и твердых лекарственных форм и косметических изделий | |
| RU2027431C1 (ru) | Средство для ухода за кожей | |
| JPS60501506A (ja) | 化粧用、健康維持用及び身体保護用組成物 | |
| DD231986A5 (de) | Verfahren zur herstellung medizinisch- kosmetischer praeparate | |
| CN1123297C (zh) | 一种富锌猪血粉的生产方法 | |
| SU1710059A1 (ru) | Препарат дл лечени дегидратации у тел т | |
| CN113105284A (zh) | 一种库拉索芦荟营养强化剂及其应用 | |
| BE900935A (fr) | Procede de preparation de compositions cosmetiques medicinales. | |
| CN107890108A (zh) | 一种抗皮肤氧化的sod保健品 | |
| HU9402176D0 (en) | Treatment of malignant cells |